Tuesday, June 22, 2021

Bharat Biotech’s Covaxin recommended for phase 2/3 trials on 2-18 year-olds

Must Read

Amid complaints over Amazon and Flipkart, India plans tighter e-commerce rules | World News

For breaking news and live news updates, Join us on Whatsapp India proposed banning flash sales on e-commerce websites...

Senior Qatari diplomat says Indian officials engaged in talks with Taliban | World News

For breaking news and live news updates, Join us on Whatsapp A senior Qatari diplomat, involved in the Afghan...

Covid-19 vaccines losing effect against Delta variant, says WHO official | World News

For breaking news and live news updates, Join us on Whatsapp Covid-19 vaccines are showing signs of reduced efficacy...

For breaking news and live news updates, Join us on Whatsapp

Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is being used in adults in India’s ongoing Covid-19 vaccination drive.

PTI | , New Delhi

PUBLISHED ON MAY 12, 2021 09:18 AM IST

Bharat Biotech’s Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said.

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

The Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech’s application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years. “After detailed deliberation, the committee recommended for conduct of proposed phase II/III clinical trial of whole virion inactivated coronavirus vaccine in the 2 to 18 years age group subject to the condition that the firm should submit the interim safety data of phase II clinical trial along with DSMB recommendations to the CDSCO before proceeding to phase III part of the study,” a source said.

Earlier the proposal was deliberated in the SEC meeting dated February 24 and the firm was asked to submit a revised clinical trial protocol.

Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is being used in adults in India’s ongoing Covid-19 vaccination drive.

Close

For breaking news and live news updates, like us on Facebook or Whatsapp or follow us on Twitter and Linkedin. Read more on Latest India News on Smart Newsline



Latest News

Saif Ali Khan and Taimur Ali Khan twin as they practice yoga at home, Kareena Kapoor shares pics | Bollywood

For breaking news and live news updates, Join us on Whatsapp Kareena Kapoor Khan has shared pictures of her husband, actor Saif Ali Khan...

Shah Rukh Khan’s daughter Suhana Khan heads to the gym after a fun weekend with friends, see pic | Bollywood

For breaking news and live news updates, Join us on Whatsapp Suhana Khan has shared a new picture on her Instagram Stories on Monday....

Janhvi Kapoor twerks, gives piggyback ride in new video; Arjun Kapoor has hilarious reaction | Bollywood

For breaking news and live news updates, Join us on Whatsapp Janhvi Kapoor has announced the return of her 'Aksa gang' with a hilarious...

Akshay Kumar busts another FAKE news, denies doing Sajid Nadiadwala’s next with Ahan Shetty | Bollywood

For breaking news and live news updates, Join us on Whatsapp The man has so many films in hand, that every day, a new...

More Articles Like This